For stem cells to be used in tissue engineering a scaffold is essential to provide the necessary support for the transport of nutrients, oxygen and the elimination of metabolic waste, promoting a conducive environment for cell growth and differentiation. Tissue engineering aims to the generation of 3d cardiac tissue with a. Especially in cardiovascular medicine, initial reports on the potential of using stem cells to recover cardiac function and replace organ subunits such as heart valves seemed to offer the promise of widespread clinical use in the near future. Future challenges of stem cellbased cardiac tissue engineering. Towards this goal, cardiac tissue engineering is now being investigated as an approach to support cell based therapies and enhance their efficacy. Stem cellbased cardiovascular tissue engineering infoscience. Current status of induced pluripotent stem cells in. Bone marrowderived stem cells mesenchymal stem cells. Review article strategies affording prevascularized cell. Challenges in cardiac tissue engineering tissue engineering.
Full text cardiac tissue engineering and regeneration. For example, ex vivo tissue engineering approaches, whereby human cardiomyogenic cells are combined with mesenchymal stem cells mscs, vasculogenic cells 42, 60, 405, andor neurons 224, 389 may be required prior to engraftment, for meaningful cardiac regeneration. Stem cells used for cardiovascular tissue engineering. Human induced pluripotent stem cell derived cardiomyocytes hipsccms. To better construct functional 3d cell sheetbased cardiac tissues, multiplelayer up to 12 layers cardiac cell sheet can be produced on a vascular bed to.
Tissue engineering approaches to regenerate myocardium involve transplantation of cells andor biomaterial scaffolds to the infarcted area. The application of escs in cardiac tissue regeneration and engineering could be tracked back to 2002. Stem cellbased cardiac tissue engineering, journal of. Scaffoldfree human cardiac tissue patch created from. Current phase iii clinical trials and possible nearfuture tissue engineering trials implementing mscs for cardiac repair will turn the page to the next chapter of heart disease treatments. The cardiac tissue is then replaced with nonfunctional fibrotic scar tissue rather than new cardiac cells, which leaves the heart weak. Normal wound healing is a dynamic and complex multiple phase process involving coordinated interactions between growth factors, cytokines, chemokines, and various cells. The main approach of cardiac tissue engineering is to create cardiac grafts, either. Toward this end, stem cells, including cardiac stem cells cscs 20, embryonic stem cells 21, bone marrowderived mesenchymal stem cells 22, and cordderived mesenchymal stem cells 23 are essential materials for cellbased tissue engineering applica. Stem cell derived cell sheet based cardiac tissue engineering has already shown more beneficial effects in mi than direct injection or the administration of stem cells with 3d scaffolds. Mesenchymal stem cellbased therapy for cardiovascular. Human embryonic stem cells were differentiated to cardiomyocytes using activin a and bmp4 and placed into suspension on a rotating orbital shaker. The integration of advanced biomaterials and stem cells has offered enormous promises for regeneration of damaged myocardium. We will present an overview of the central approaches focusing on pluripotent stem cellderived cells, mechanisms of action, autologous vs.
Nanoenabled approaches for stem cell based cardiac tissue engineering 19 may 2016 advanced healthcare materials, vol. The cellbased but not necessarily stem cellbased nature of tissue engineering served to define it, and to distinguish it from guided tissue regeneration in which a scaffold is designed to. Application of injectable hydrogels for cardiac stem cell. Engineered biomaterials also have applications in cardiac tissue engineering, in which tissue constructs are developed in vitro by combining stem cells and biomaterial scaffolds for drug screening or eventual implantation. It may not be necessary or desirable to culture a noncardiogenic tissue patch in vitro for extended time periods before implantation, whereas the use of cardiogenic cells to create tissue patches with structure and function resembling those of native cardiac muscle will require specialized and wellcontrolled culture conditions. Cellbased therapy in cardiac regeneration circulation.
Stem cellderived cell sheetbased cardiac tissue engineering has already shown more beneficial effects in mi than direct injection or the administration of stem cells with 3d scaffolds. Virtues of this polysiloxanebased polymer include delivery of. Current status of induced pluripotent stem cells in cardiac. Additionally, stem cell based strategies, consisting of cell transplantation and cardiac tissue engineering, will be addressed to compare their features and limitations. From the laboratory for stem cells and tissue engineering, columbia university. Adult stem cells for cardiac tissue engineering sciencedirect. With these technologies, advancements are being made into therapies for acute ischemic myocardial injury and chronic, otherwise nonreversible, myocardial failure. The failure of the neuroprotective paradigm and limited eligibility for thrombolysis spawned an interest in stem cellbased neurorestoration, 6 which is characterized by a wide therapeutic window and is highly convergent with rehabilitation. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cellderived cardiovascular cells. Cardiac tissue engineering aims to develop functional acellular or cellular tissue constructs that can efficiently repair and regenerate the infarcted myocardium to resume its native form and function. Strategies affording prevascularized cellbased constructs. Recently, a cellbased regenerative medicine has appeared as one of the most potential and promising therapies for improving cardiac diseases. However, cell survival and engraftment posttransplantation are major limitations that must be addressed prior to widespread use of this technology. Cardiac tissue engineering an overview sciencedirect.
As a new generational cellbased regenerative therapy, tissue engineering is focused. Additionally, it has been shown that when delivered to the in vivo heart tissue, these scaffolds have the potential to promote stem cell differentiation, cardiac regeneration, and angiogenesis. To better construct functional 3d cell sheet based cardiac tissues, multiplelayer up to 12 layers cardiac cell sheet can be produced on a vascular bed to. Recently, mscbased tissue engineering studies for heart disease have shown encouraging findings, but translation to the clinical setting is still required. Many tissue engineering interventions certainly have potential, and new stem cell techniques are poised to help advance these treatments into the scope of cardiovascular nursing.
Towards this goal, cardiac tissue engineering is now being investigated as an approach to support cellbased therapies and enhance their efficacy. Furthermore, cardiac stem cellbased tissue engineering approaches could also be designed to stimulate cardiac resident nonstem cells that may also release factors such as vegf and hgf that may also act in an autocrine and paracrine fashion to modulate antiapoptotic, antiremodeling and angiogenic responses. The development of new biomaterials for tissue engineering provides a scientific basis. Tissue engineers must have a thorough understanding of the cues that guide multiple cell types to form functional tissue. Since adult cardiac cells are limited in their proliferation, cardiac tissue with dead or damaged cardiac cells downstream of the occluded vessel does not regenerate after myocardial infarction. Bioactive scaffolds in stemcellbased therapies for. The production of a functional cardiac tissue to be transplanted in the injured area of the infarcted myocardium represents a challenge for regenerative medicine. Cells are thought to operate either directly, by replacing the unhealthy cells in the damaged tissue, or indirectly, via the secretion of molecules and microvesicles that stimulate endogenous mecha. Engineered biomaterials also have applications in cardiac tissue engineering, in which tissue constructs are developed in vitro by combining stem cells and biomaterial scaffolds for drug screening. The impact of stem cell technology on tissue engineering will be revolutionary. Pdf stem cellbased cardiac tissue engineering researchgate. Our laboratory has originally developed cell sheetbased scaffoldfree tissue.
Tissue engineering strategies aim at developing efficient therapeutic approaches to overcome the current challenges in prolonging patients survival upon cardiac diseases. Key results of allogeneic and autologous stem cell trials are presented, including the use of embryonic, bone marrowderived, adiposederived, and resident cardiac stem cells. Stem cell therapy and tissue engineering for correction of. This book covers stateoftheart knowledge on the potential of stem cells for the regeneration of a wide range of tissues and organs. Future challenges of stem cell based cardiac tissue engineering. Stem cellbased tissue replacement after stroke stroke. Stem cell therapy has provided first proofofconcept, thus paving the way to tissue engineering to fabricate cellularized valves endowed with anticoagulative properties and living cardiac tissue that grows physiologically in parallel with the heart s growth. As methods and disciplines merge, the ability to regenerate cardiac tissue is a goal with incalculable benefits from benchtop to bedside.
Cardiac tissue engineering and regeneration using cellbased. Biomaterial approaches for stem cellbased myocardial. The cell based therapies are performed by using the injection of dissociated cells, scaffold based tissue engineering, and cell sheet based tissue engineering. Cardiac tissue engineering an overview sciencedirect topics. The cellbased therapies are performed by using the injection of dissociated cells, scaffoldbased tissue engineering, and cell sheetbased tissue engineering. Stem cell therapy and tissue engineering represent a forefront of current research in the treatment of heart disease. Introduction one of the most ambitious objectives for cardiac tissue engineering aimed at repairing an infarcted cardiac region is the production of a stem cellbased functional tissue that. However, stem cellbased tissue replacement may be aggravated by pathophysiological and anatomic. Stem cellbased therapy through genome editing techniques can repair gene mutation, control better maturation of cms or even reveal its. Based on this knowledge and potential, human embryonic stem cells. In this backstory, cell stem cell senior scientific editor jonathan saxe presents a case study of two cell stem cell papers published in 2018.
Engineered biomaterials also have applications in cardiac tissue engineering, in which tissue constructs are developed in vitro by combining stem cells and. The recent advancement of stem cell biology provides enormous opportunities to engineer stem cells for tissue engineering. Regenerative therapies using cell sheetbased tissue. Cardiac tissue engineering and regeneration using cellbased therapy mohammad t alrefai, divya murali,4 arghya paul,4 khalid m ridwan,1,2 john m connell,1,2 dominique shumtim1,2 1division of cardiac surgery, 2division of surgical research, mcgill university health center, montreal, qc, canada. As the field of cardiac tissue regeneration develops novel protocols for stem cell based therapies, visualizations that didactically convey in vitro spatiotemporal cell cell interactions become increasingly important to. The limited proliferation ability of host cardiac cells has motivated investigators to research the potential cardiac regenerative ability of stem cells. Cardiac cellbased therapies aim to overcome the limitations of gene therapy via the adoptive transfer of healthy cells, rather than isolated genes. Additionally, stem cellbased strategies, consisting of cell transplantation and cardiac tissue engineering, will be addressed to compare their features and limitations. Pdf stem cellbased cardiovascular tissue engineering. We have developed a novel method to deliver stem cells using 3d bioprinted cardiac patches, free of biomaterials.
Considerable progress has been made in this endeavor. At present, cardiac diseases are a major cause of morbidity and mortality in the world. Furthermore, cardiac stem cell based tissue engineering approaches could also be designed to stimulate cardiac resident non stem cells that may also release factors such as vegf and hgf that may also act in an autocrine and paracrine fashion to modulate antiapoptotic, antiremodeling and angiogenic responses. Our goal was to improve cardiac function after myocardial infarction through hes based cardiovascular tissue engineering. Most cell based grafts are unviable because of inadequate perfusion. Cardiac tissue engineering and regeneration using cellbased therapy. Using this model, the authors identify two hit compounds that restart cardiomyocyte proliferation by synergistically activating the mevalonate pathway and cell. Stem cell research and tissue engineering have become leading fields in basic research worldwide. Our goal was to improve cardiac function after myocardial infarction through hesbased cardiovascular tissue engineering.
May 14, 2015 stem cell therapy and tissue engineering represent a forefront of current research in the treatment of heart disease. The cardiac tissue is then replaced with nonfunctional fibrotic scar tissue rather than new. Stem cellderived cell sheet transplantation for heart tissue. Primarily a wide range of biomaterials, along with different types of stem cells, which have utilized in cardiac tissue engineering will be. Toward this end, stem cells, including cardiac stem cells cscs, embryonic stem cells, bone marrowderived mesenchymal stem cells, and cordderived mesenchymal stem cells are essential materials for cell based tissue engineering applications. Tissue engineering in a classical sense implies the use of organspecific cells for seeding a scaffold ex vivo. Cardiac tissue engineering and regeneration using cell. Most cellbased grafts are unviable because of inadequate perfusion. Reduction of adverse cardiac scarring facilitates pluripotent stem cellbased therapy for myocardial infarction jialiang liang,a wei huang,a lin jiang,a christian paul,a xiangnan li,a,b yigang wanga key words. Types of stem cell for cardiac therapy by definition, stem cells are undifferentiated cells that are clonogenic, selfrenewing, and pluripotent or multi potent. Biomaterialfree threedimensional bioprinting of cardiac. Any failure in these phases may lead wounds to become chronic and have abnormal scar formation. Nov 23, 2019 kharaziha m, memic a, akbari m, brafman da, nikkhah m 2016 nanoenabled approaches for stem cellbased cardiac tissue engineering. To this aim, cells with a differentiation potential towards vascular.
Nanotechnologybased stem cell tissue engineering with a. Cardiac cell based therapies aim to overcome the limitations of gene therapy via the adoptive transfer of healthy cells, rather than isolated genes. These properties are met in polyurethanebased scaffoldsfigure 2, and. Tissue engineering of the heart the journal of thoracic and. Reduction of adverse cardiac scarring facilitates pluripotent. Stem cellbased cardiac tissue engineering springerlink. Cells aggregated to form macroscopic discshaped patches of beating tissue after 2 days. Pluripotent stem cells fibrosis cell therapy tissue stiffness cardiomyocytes. Here we report a novel and scalable method to generate scaffoldfree human cardiac tissue patches. Jul 12, 2011 cardiovascular diseases are the leading cause of death worldwide, and cell based therapies represent a potential cure for patients with cardiac diseases such as myocardial infarction, heart failure, and congenital heart diseases. Nanoenabled approaches for stem cellbased cardiac tissue engineering 19 may 2016 advanced healthcare materials, vol. The cell based but not necessarily stem cell based nature of tissue engineering. Pdf cardiovascular diseases are the leading cause of death worldwide, and cellbased therapies represent a potential cure for patients with cardiac.
665 1048 1424 586 730 1535 1296 1073 247 1508 1291 1503 439 599 1597 1642 1451 570 372 138 1188 1237 219 774 178 1561 106 24 819 318 1620 755 1649 1390 1055 755 462 33 796 105 118 820 146 993 1367 856 247